C12Y 402/01022
Cystathionine beta-synthase
Official title: Cystathionine beta-synthase (4.2.1.22)
C12Y402/01022 (Cystathionine beta-synthase) appears on 29 US grants and 39 published applications in this corpus.
Search patents in C12Y- Granted patents
- 29
- Published applications
- 39
- Assignees
- 16
- Inventors
- 44
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 0 | 2 |
| 2015 | 2 | 2 |
| 2016 | 3 | 5 |
| 2017 | 2 | 4 |
| 2018 | 2 | 2 |
| 2019 | 4 | 4 |
| 2020 | 3 | 5 |
| 2021 | 2 | 0 |
| 2022 | 2 | 5 |
| 2023 | 2 | 2 |
| 2024 | 1 | 1 |
| 2025 | 2 | 3 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for treatment of homocystinuria23 Jun 2026US 12,661,391 B2The Regents of the University of Colorado, a body corporate
- Pegylated cystathionine beta synthase for enzyme therapy for treatment of homocystinuria22 Jul 2025US 12,364,765 B2The Regents of the University of Colorado, a body corporate
- Compositions and methods for treatment of homocystinuria14 Jan 2025US 12,194,082 B2The Regents of the University of Colorado, a body corporate
- Optimization of enzyme replacement therapy for treatment of homocystinuria23 Jul 2024US 12,042,529 B2The Regents of the University of Colorado, a body corporate
- Methods for high taurine production using novel decarboxylases3 Oct 2023US 11,771,114 B2Plant Sensory Systems, LLC
- Cysteine prototrophy2 Oct 2025US 2025/0304911 A1Pfizer Inc.
- Cellular reprogramming by targeting the golgi apparatus29 May 2025US 2025/0170239 A1MUSC Foundation for Research Development
- Compositions and methods for treatment of homocystinuria6 Feb 2025US 2025/0041392 A1The Regents of the University of Colorado, a body corporate
- Compositions and methods for treatment of homocystinuria21 Mar 2024US 2024/0091325 A1The Regents of the University of Colorado, a body corporate
- Optimization of enzyme replacement therapy for treatment of homocystinuria9 Feb 2023US 2023/0039591 A1The Regents of the University of Colorado, a body corporate
Most cited
By later US patents
- Human cystathionine β-synthase variants and methods of production thereof22US 7,485,307 B2The Regents of the University of Colorado · 2009
- Human cystathionine β-synthase variants and methods of production thereof18US 8,007,787 B2The Regents of the Universit of Colorado · 2011
- Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria16US 9,034,318 B2The Regents of the University of Colorado, a body corporate · 2015
- Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria12US 9,447,406 B2The Regents of the University of Colorado, a body corporate · 2016
- Compositions and methods for treatment of homocystinuria10US 9,675,678 B2The Regents of the University of Colorado, a body corporate · 2017